title: Effects of GRF(1-40) and domperidone on GH secretion in normal man.
abstract: In eight normal adult men pituitary secretion following GRF(1-40) was studied. GRF administration (50 micrograms i.v.) was followed by an increase in GH release with a peak value between the 15 and 60 min. No effects were noticed on LH, FSH, PRL, TSH and ACTH secretion. GH and PRL release was also studied after domperidone (DOM) (5 mg i.v./h), and GRF plus DOM. PRL increased significantly after DOM and GRF plus DOM. During GRF plus DOM a more marked GH release was observed in comparison with the hormone response to GRF alone at 15-45 and 120 min (P less than 0.05). This phenomenon was found in in six out of eight subjects studied. Mean peak and secretory area was greater (P less than 0.05) after GRF plus DOM than after GRF alone. These data suggest that GRF(1-40) at the dose used is a useful tool in the study of GH secretion. The GH pattern during GRF plus DOM seems to indicate that dopaminergic tone may play a direct inhibitory role on GH secretion in man.
mesh_terms: D000293:Adolescent; D000328:Adult; D004294:Domperidone / Q000494:pharmacology*; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology*; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood / Q000378:metabolism; D012636:Secretory Rate / Q000187:drug effects
chemical_list: D010446:Peptide Fragments; C036893:somatotropin releasing factor 40; D004294:Domperidone; D011388:Prolactin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone